Design and Characterization of Bispecific and Trispecific Antibodies Targeting SARS-CoV-2
our study provided several supplements to the therapeutic measures of COVID-19 based on multispecific antibodies, supporting the great potential of the multispecific antibodies strategy in dealing with emerging pathogens.
Authors
- Zuxin Liang
- Qi Qian (ORCID: https://orcid.org/0000-0002-1735-2657)
- Yushan Jiang (ORCID: https://orcid.org/0000-0001-8263-3423)
- Jiayang Wang (ORCID: https://orcid.org/0000-0002-9580-2924)
- Chenguang Shen (ORCID: https://orcid.org/0000-0001-8607-3750)
- Yang Yang (ORCID: https://orcid.org/0000-0002-4365-6179)
- Wei Zhao (ORCID: https://orcid.org/0000-0001-8440-2274)
- Yun Peng (ORCID: https://orcid.org/0000-0002-0872-4025)
Institutions
- Southern University of Science and Technology (CN)
- Zhujiang Hospital (CN)
- Shenzhen Third People’s Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Vaccines
- Published
- 2025-02-28
- DOI
- https://doi.org/10.3390/vaccines13030255
- Citations
- 2
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 2.79
Funders
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province